Top Story

Top five ophthalmology news stories this week

December 21, 2014

This week, the most frequently viewed ophthalmology articles on Healio.com ranged from topics such as the OSN New York meeting to Genentech’s receipt of the U.S. Food and Drug Administration’s breakthrough therapy designation for Lucentis.

Here are the top five most-viewed stories from December 15th to December 19th:

Publication Exclusive

OSN round table: How to become a better femtosecond laser cataract surgeon

December 20, 2014
At the European Society of Cataract and Refractive Surgeons meeting, Ocular Surgery News gathered an international panel of experts to discuss their experiences with…
Thyroidectomy, statins may reduce risk of ophthalmopathy in patients with Graves’ disease In the Journals

Thyroidectomy, statins may reduce risk of ophthalmopathy in patients with Graves’ disease

December 19, 2014
Thyroid removal and statin use diminished the risk of thyroid-associated ophthalmopathy in patients with Graves’ disease, according to study results.The longitudinal…
In the Journals

Latanoprost may preserve visual field in patients with glaucoma

December 19, 2014
The IOP-lowering drug, Xalatan, may be capable of preserving visual field in patients with open-angle glaucoma, according to results from a randomized, triple-masked…
Breaking News

Aldeyra submits IND application for phase 2 testing of uveitis treatment

December 19, 2014
Aldeyra Therapeutics has submitted an investigational new drug application to the U.S. Food and Drug Administration to conduct phase 2 clinical testing of its product…
More News Headlines »
Short Subjects

Central Retinal Vein Obstruction in a Neonate Occurring During Laser Photocoagulation Treatment for Retinopathy of Prematurity

Journal of Pediatric Ophthalmology and Strabismus, Volume -2147483648
Online Only, December 1, 2014
A premature infant who developed central retinal vein obstruction in one eye during laser therapy for high-risk…
More »
CME
boyer

In Focus: Advances in AMD - Clinical Case: Long-term Management of Established Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Long-term management of wet age-related macular degeneration can be challenging, as medications and dosing schedules…
More »
Meeting News Coverage Video
thumbnail for video 3948296533001

VIDEO: Macular therapeutics update

December 18, 2014
NEW YORK — Andrew Moshfeghi, MD, MBA, discusses recent advances in retina technology, as well as future…
More »
morganatic-roan